Get Premium to unlock powerful stock data
Second Sight Medical Products Inc logo

Second Sight Medical Products Inc

$ 1.48 +0.01 (+0.68%) 09:08 PM EST
P/E:
At Loss
P/B:
0.86
Market Cap:
$ 58.33M
Enterprise V:
$ -11.43M
Volume:
165.57K
Avg Vol (2M):
319.59K
Also Trade In:
Volume:
165.57K
Market Cap $:
58.33M
PE Ratio:
At Loss
Avg Vol (2-Month):
319.59K
Enterprise Value $:
-11.43M
PB Ratio:
0.86
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Second Sight Medical Products Inc
NAICS : 339112 SIC : 3842
13170 Telfair Avenue, Sylmar, CA, USA, 91342
Description
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 293.64
Equity-to-Asset 0.97
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -3.15
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.32
9-Day RSI 46.79
14-Day RSI 49.75
6-1 Month Momentum % -58.94
12-1 Month Momentum % -72.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 28.64
Quick Ratio 28.64
Cash Ratio 28.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -60.4
Name Current Vs Industry Vs History
ROE % -19.36
ROA % -17.63
ROIC % -437.81
ROC (Joel Greenblatt) % -2405.22
ROCE % -19.34

Financials (Next Earnings Date:2022-08-12 Est.)

EYES's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:EYES

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.28
Beta 3.74
Volatility % 34.91
14-Day RSI 49.75
14-Day ATR ($) 0.120802
20-Day SMA ($) 1.47875
12-1 Month Momentum % -72.5
52-Week Range ($) 1.14 - 7.64
Shares Outstanding (Mil) 39.41

Piotroski F-Score Details

Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Second Sight Medical Products Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More